Acetylsalicylic acid Completed Phase 2 Trials for Lupus / Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00054938Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)